tetano
Editor, Senior Moderator
Ann Clin Microbiol Antimicrob
. 2021 Apr 27;20(1):31.
doi: 10.1186/s12941-021-00436-9.
Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross-sectional study
Aziz Ogutlu[SUP] 1 [/SUP], Oguz Karabay[SUP] 2 [/SUP], Unal Erkorkmaz[SUP] 3 [/SUP], Ertugrul Guclu[SUP] 2 [/SUP], Seher Sen[SUP] 4 [/SUP], Abdulkadir Aydin[SUP] 5 [/SUP], Mehmet Koroglu[SUP] 6 [/SUP]
Affiliations
Abstract
Background: This study aimed to investigate the specific risk factors for the transmission of novel coronavirus (SARS-CoV-2) among healthcare workers in different campuses of a university hospital and to reveal the risk factors for antibody positivity.
Methods: In this retrospective cross-sectional study, 2988 (82%) of 3620 healthcare workers in a university hospital participated. The coronavirus disease 2019 (COVID-19) antibody was investigated using serum from healthcare workers who underwent COVID-19 antibody testing. The antibody test results of the participants were evaluated based on their work campus, their profession and their workplace. The statistical significance level was p < 0.05 in all analyses.
Results: Of the participants in this study, 108 (3.6%) were antibody positive, and 2880 (96.4%) were negative. Antibody positivity rates were greater in nurses compared with other healthcare workers (p < 0.001). Regarding workplace, antibody positivity was greater in those working in intensive care compared to those working in other locations (p < 0.001).
Conclusions: Healthcare workers are at the highest risk of being infected with COVID-19. Those who have a higher risk of infection among healthcare workers and those working in high-risk areas should be vaccinated early and use personal protective equipment during the pandemic.
Trial registration: Retrospective permission was obtained from both the local ethics committee and the Turkish Ministry of Health for this study (IRB No:71522473/050.01.04/370, Date: 05.20.2020).
Keywords: Antibody; COVID-19; Pandemic.
. 2021 Apr 27;20(1):31.
doi: 10.1186/s12941-021-00436-9.
Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross-sectional study
Aziz Ogutlu[SUP] 1 [/SUP], Oguz Karabay[SUP] 2 [/SUP], Unal Erkorkmaz[SUP] 3 [/SUP], Ertugrul Guclu[SUP] 2 [/SUP], Seher Sen[SUP] 4 [/SUP], Abdulkadir Aydin[SUP] 5 [/SUP], Mehmet Koroglu[SUP] 6 [/SUP]
Affiliations
- PMID: 33902614
- DOI: 10.1186/s12941-021-00436-9
Abstract
Background: This study aimed to investigate the specific risk factors for the transmission of novel coronavirus (SARS-CoV-2) among healthcare workers in different campuses of a university hospital and to reveal the risk factors for antibody positivity.
Methods: In this retrospective cross-sectional study, 2988 (82%) of 3620 healthcare workers in a university hospital participated. The coronavirus disease 2019 (COVID-19) antibody was investigated using serum from healthcare workers who underwent COVID-19 antibody testing. The antibody test results of the participants were evaluated based on their work campus, their profession and their workplace. The statistical significance level was p < 0.05 in all analyses.
Results: Of the participants in this study, 108 (3.6%) were antibody positive, and 2880 (96.4%) were negative. Antibody positivity rates were greater in nurses compared with other healthcare workers (p < 0.001). Regarding workplace, antibody positivity was greater in those working in intensive care compared to those working in other locations (p < 0.001).
Conclusions: Healthcare workers are at the highest risk of being infected with COVID-19. Those who have a higher risk of infection among healthcare workers and those working in high-risk areas should be vaccinated early and use personal protective equipment during the pandemic.
Trial registration: Retrospective permission was obtained from both the local ethics committee and the Turkish Ministry of Health for this study (IRB No:71522473/050.01.04/370, Date: 05.20.2020).
Keywords: Antibody; COVID-19; Pandemic.